Myrbetriq is a prescription medicine for adults used to treat
overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Why Myrbetriq?

In this section, you'll learn about:

Treating OAB with Myrbetriq
How it works
Starting a conversation with your doctor
Possible side effects

Text to Save!

Tap here to text MSAVINGS to 26789 and get your first Myrbetriq prescription at no cost.^#

^#Subject to eligibility. Restrictions may apply. No-cost offer applies to one-month prescriptions only.
Not available to patients paying cash.
Msg & data rates may apply. Msg frequency varies. Text HELP for info, STOP to end.

For the Momentum Program, tap here for applicable Terms and Conditions. View Privacy Policy.

Text to Save!

Text MSAVINGS to 26789 to get your first Myrbetriq prescription at no cost.^#

^#Subject to eligibility. Restrictions may apply. No-cost offer applies to one-month prescriptions only. Not available to patients paying cash.
Msg & data rates may apply. Msg frequency varies. Text HELP for info, STOP to end.

For the Momentum Program, click here for applicable Terms and Conditions. View Privacy Policy.

For Text to Save, click here to view Eligibility and Terms and Conditions. For Text to Save, tap here to view Eligibility and Terms and Conditions.

What is Myrbetriq
used for?

Myrbetriq is a prescription medicine for adults approved by the U.S. Food and Drug Administration (FDA) to treat the overactive bladder symptoms of urgency, frequency, and leakage.

Myrbetriq was shown in studies to be effective in treating OAB symptoms of urgency,
frequency and leaks within the first 4 to 8 weeks.

why myrbetriq for overactive bladder treatment, oab

Myrbetriq is a prescription medicine for adults approved by the U.S. Food and Drug Administration (FDA) to treat the overactive bladder symptoms of urgency, frequency, and leakage.

Myrbetriq was shown in studies to be effective in treating OAB symptoms of urgency, frequency and leaks within the first 4 to 8 weeks.

If you have OAB symptoms of urgency, frequency and leakage, ask your healthcare professional (HCP) if Myrbetriq may be right for you.

Myrbetriq is the #1 prescribed* branded medication for OAB

*Based on 24-month TRx shares for all branded OAB medications, IMS Health National Prescription Audit, January 2019‑December 2020.
THIS INFORMATION DOES NOT IMPLY SAFETY OR EFFICACY OF ANY PRODUCT; NO COMPARISONS SHOULD BE MADE.

What to Expect from Myrbetriq

Less
Urgency

Less
Frequency

Less
Leakage

Your results may vary.

If you have OAB symptoms of urgency, frequency and leakage, ask your healthcare professional (HCP) if Myrbetriq
may be right for you.

How Does Myrbetriq Work?

With OAB, the bladder muscle suddenly contracts before the bladder is full. This causes frequent and sudden urges to urinate that may be uncontrollable. These urges can sometimes lead to leakage or accidental wetting.

When taken as directed, it can help relax the smooth muscle that surrounds the bladder and increase the bladder's ability to store urine.

Your doctor may prescribe Myrbetriq if you:

Take too many trips to the bathroom
Have frequent leaks and accidents
Have already tried other treatment options

See for Yourself How Myrbetriq Works

Watch these videos to learn more about your bladder and Myrbetriq

talking to your doctor about overactive bladder, oab

Myrbetriq: How It Works

Noted Urologist Dr. David Staskin
discusses
OAB and Myrbetriq.

how myrbetriq works for overactive bladder, oab

How Myrbetriq Works in the Body

Watch an animated explanation of
Myrbetriq at work.

Find a specialist to talk to about your OAB symptoms

What Are the Possible Side Effects of Myrbetriq?

Do not take Myrbetriq if you have an allergy
to mirabegron or any of the ingredients
in Myrbetriq.

Myrbetriq may cause serious side effects including:

Increased blood pressure:
Myrbetriq may
cause your blood pressure to increase or make
your blood pressure worse if you have a history
of high blood pressure. You and your doctor
should check your blood pressure while you are taking Myrbetriq. Call your doctor if you have increased blood pressure.

Inability to empty your bladder
(urinary retention):
Myrbetriq may increase your
chances of not being able to empty your
bladder if you have bladder outlet obstruction
or if you are taking other medicines to treat overactive bladder.
Tell your doctor right away if you are unable to empty your bladder.

Angioedema:
Myrbetriq may cause an allergic
reaction with swelling of the lips, face, tongue,
or throat with or without difficulty breathing. Stop
using Myrbetriq and go to the nearest hospital emergency room right away.

Most common reported side effects of Myrbetriq
in a 52‑week study of 812 patients

HOW SIDE EFFECTS OF MYRBETRIQ
WERE DETERMINED:

The 52‑week Myrbetriq Safety Study Explained:: The study involved 812 patients taking Myrbetriq 50 mg 1 time a day for up to 52 weeks. Patients reported their side effects. Another group of 812 patients were given the standard treatment (Active Control), and they reported their side effects.; Most common side effects reported by greater than 3% of patients treated with Myrbetriq 50 mg 1 time a day in Study 4.
What is an ‘Active Control’ for clinical studies?: This is the name for the standard treatment people with a certain condition are given.

Click on the side effect(s) to see the percentage of patients who were affected

Percentage of patients who experienced side effect

Myrbetriq 50 mg
9.2%

Active Control
9.6%

Percentage of patients who experienced side effect

Myrbetriq 50 mg
4.1%

Active Control
2.5%

Percentage of patients who experienced side effect

Myrbetriq 50 mg
5.9%

Active Control
6.4%

Percentage of patients who experienced side effect

Myrbetriq 50 mg
3.9%

Active Control
3.1%

Percentage of patients who experienced side effect

Myrbetriq 50 mg
9.2%

Active Control
9.6%

Percentage of patients who experienced side effect

Myrbetriq 50 mg
4.1%

Active Control
2.5%

Percentage of patients who experienced side effect

Myrbetriq 50 mg
5.9%

Active Control
6.4%

Percentage of patients who experienced side effect

Myrbetriq 50 mg
3.9%

Active Control
3.1%

Tell your doctor if you have any side effect that bothers you or that does not go away or if you have swelling of the face, lips, tongue, or throat, hives, skin rash or itching while taking Myrbetriq. These are not all the possible side effects of Myrbetriq. For more information, ask
your doctor or pharmacist.

What is MYRBETRIQ? MYRBETRIQ is a prescription medicine for adults that can be used alone or with solifenacin succinate to treat the following symptoms due to a condition called overactive bladder:

Urge urinary incontinence: a strong need to urinate with leaking or wetting accidents
Urgency: a strong need to urinate right away
Frequency: urinating often

How should I take MYRBETRIQ

If your doctor prescribes MYRBETRIQ and solifenacin succinate together, you should take 1 MYRBETRIQ tablet and 1 solifenacin tablet at the same time, 1 time a day.
You should take MYRBETRIQ with water and swallow the tablet whole.
Do not chew, break, or crush the tablet.
You can take MYRBETRIQ with or without food.
You can take MYRBETRIQ and solifenacin succinate together with or without food.
If you miss a dose of MYRBETRIQ tablets, take it as soon as possible. If it has been more than 12 hours since taking the last dose of MYRBETRIQ tablets, skip that dose and take the next dose at the usual time.
If you take too much MYRBETRIQ tablets, call your doctor or go to the nearest hospital emergency room right away.

The most common side effects of MYRBETRIQ, when used with solifenacin succinate, include:

dry mouth
urinary tract infection
constipation
fast heartbeat

USE OF MYRBETRIQ MYRBETRIQ^® (mirabegron extended-release tablets) is a prescription medicine for adults that can be used alone or with solifenacin succinate to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

IMPORTANT SAFETY INFORMATION FOR MYRBETRIQ Do not take MYRBETRIQ if you are allergic to mirabegron or any ingredients in MYRBETRIQ.

MYRBETRIQ may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. You and your doctor should check your blood pressure while you are taking MYRBETRIQ. Call your doctor if you have increased blood pressure.

MYRBETRIQ may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or if you have a weak urine stream.

MYRBETRIQ may cause an allergic reaction with swelling of the face, lips, throat or tongue with or without difficulty breathing. Stop using MYRBETRIQ tablets and go to the nearest hospital emergency room right away.

Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines especially thioridazine (Mellaril™ and Mellaril-S™), flecainide (Tambocor^®), propafenone (Rythmol^®), digoxin (Lanoxin^®), or solifenacin succinate (VESIcare^®). MYRBETRIQ may affect the way other medicines work, and other medicines may affect how MYRBETRIQ works.

Before taking MYRBETRIQ, tell your doctor about all of your medical conditions, including if you have liver or kidney problems.

The most common side effects of MYRBETRIQ include high blood pressure, pain or swelling of the nose or throat (nasopharyngitis), urinary tract infection, and headache.

The most common side effects of MYRBETRIQ, when used with solifenacin succinate, include dry mouth, urinary tract infection, constipation, and fast heartbeat.

Please refer to the solifenacin succinate Patient Product Information and complete Prescribing Information when taking in combination with MYRBETRIQ.

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for MYRBETRIQ^® (mirabegron extended‑release tablets).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.

Myrbetriq, Astellas, and the flying star logo are registered trademarks of Astellas Pharma Inc. All other trademarks or registered trademarks are the property of their respective owners.

What People Are Saying

Living With OAB

Living With OAB

What People Are Saying

Use of Myrbetriq and
Important Safety Information

Do not take MYRBETRIQ® (mirabegron extended-release tablets) if you are allergic to mirabegron or any ingredients in MYRBETRIQ. MYRBETRIQ may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. You and your doctor should check your blood pressure while you are taking MYRBETRIQ.

Use of Myrbetriq

MYRBETRIQ® (mirabegron extended-release tablets) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Important Safety Information

Do not take MYRBETRIQ if you are allergic to mirabegron or any ingredients in MYRBETRIQ.

MYRBETRIQ may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. You and your doctor should check your blood pressure while you are taking MYRBETRIQ. Call your doctor if you have increased blood pressure.

MYRBETRIQ may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream.

MYRBETRIQ may cause an allergic reaction with swelling of the face, lips, throat or tongue with or without difficulty breathing. Stop using MYRBETRIQ and go to the nearest hospital emergency room right away.

Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines especially thioridazine (Mellaril™ and Mellaril-S™), flecainide (Tambocor®), propafenone (Rythmol®), digoxin (Lanoxin®) or solifenacin succinate (VESIcare®). MYRBETRIQ may affect the way other medicines work, and other medicines may affect how MYRBETRIQ works.

Before taking MYRBETRIQ, tell your doctor about all of your medical conditions, including if you have liver or kidney problems.

The most common side effects of MYRBETRIQ include high blood pressure, pain or swelling of the
nose or throat (nasopharyngitis), urinary tract infection, and headache.

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for MYRBETRIQ^® (mirabegron extended‑release tablets).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Use of Myrbetriq

MYRBETRIQ® (mirabegron extended-release tablets) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Important Safety Information

Do not take MYRBETRIQ if you are allergic to mirabegron or any ingredients in MYRBETRIQ.

MYRBETRIQ may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. You and your doctor should check your blood pressure while you are taking MYRBETRIQ. Call your doctor if you have increased blood pressure.

MYRBETRIQ may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream.

MYRBETRIQ may cause an allergic reaction with swelling of the face, lips, throat or tongue with or without difficulty breathing. Stop using MYRBETRIQ and go to the nearest hospital emergency room right away.

Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines especially thioridazine (Mellaril™ and Mellaril-S™), flecainide (Tambocor®), propafenone (Rythmol®), digoxin (Lanoxin®) or solifenacin succinate (VESIcare®). MYRBETRIQ may affect the way other medicines work, and other medicines may affect how MYRBETRIQ works.

Before taking MYRBETRIQ, tell your doctor about all of your medical conditions, including if you have liver or kidney problems.

The most common side effects of MYRBETRIQ include high blood pressure, pain or swelling of the
nose or throat (nasopharyngitis), urinary tract infection, and headache.

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for MYRBETRIQ^® (mirabegron extended‑release tablets).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.